Description
XenForo before 2.3.13 contains an OAuth2 authorization code reuse vulnerability that allows attackers to obtain unauthorized token pairs by submitting a previously used authorization code. Attackers can exploit the failure to invalidate or mark authorization codes as consumed after initial token issuance to receive an independent token pair for the same user and scopes, bypassing the single-use guarantee of the OAuth2 authorization code flow.
Published: 2026-09-08
Score: 9.1 Critical
EPSS: n/a
KEV: No
Impact: n/a
Action: n/a
AI Analysis

Analysis and contextual insights are available on OpenCVE Cloud.

Remediation

No vendor fix or workaround currently provided.

Additional remediation guidance may be available on OpenCVE Cloud.

Tracking

Sign in to view the affected projects.

Advisories

No advisories yet.

History

Tue, 08 Sep 2026 13:30:00 +0000

Type Values Removed Values Added
Description XenForo before 2.3.13 contains an OAuth2 authorization code reuse vulnerability that allows attackers to obtain unauthorized token pairs by submitting a previously used authorization code. Attackers can exploit the failure to invalidate or mark authorization codes as consumed after initial token issuance to receive an independent token pair for the same user and scopes, bypassing the single-use guarantee of the OAuth2 authorization code flow.
Title XenForo < 2.3.13 OAuth2 Authorization Code Reuse
Weaknesses CWE-294
References
Metrics cvssV3_1

{'score': 7.4, 'vector': 'CVSS:3.1/AV:N/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:N'}

cvssV4_0

{'score': 9.1, 'vector': 'CVSS:4.0/AV:N/AC:H/AT:N/PR:N/UI:N/VC:H/VI:H/VA:N/SC:N/SI:N/SA:N'}


Subscriptions

No data.

cve-icon MITRE

Status: PUBLISHED

Assigner: VulnCheck

Published:

Updated: 2026-09-08T13:16:31.988Z

Reserved: 2026-08-11T19:56:20.007Z

Link: CVE-2026-73311

cve-icon Vulnrichment

No data.

cve-icon NVD

Status : Received

Published: 2026-09-08T14:17:25.220

Modified: 2026-09-08T14:17:25.220

Link: CVE-2026-73311

cve-icon Redhat

No data.

cve-icon OpenCVE Enrichment

No data.

Weaknesses